Echo Street Capital Management LLC Edwards Lifesciences Corp Transaction History

Echo Street Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$69.28 - $93.38 $773,580 - $1.04 Million	11,166 New	11,166 $773,000
Q4 2022 Feb 13, 2023	BUY	$68.3 - $87.44 $117,271 - $150,134	1,717 Added 69.01%	4,205 $313,000
Q3 2022 Nov 14, 2022	BUY	$82.37 - $107.29 $204,936 - $266,937	2,488 New	2,488 $206,000
Q3 2020 Nov 16, 2020	SELL	$67.19 - $87.44 $1.61 Million - $2.1 Million	-24,023 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$57.54 - $76.95 $1.38 Million - $1.85 Million	24,023 New	24,023 $1.66 Million

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Echo Street Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Echo Street Capital Management LLC with notifications on news.